WHO ICTRP trial
A Multi-center Study to Evaluate How CCP-020 (Diacerein 1% ointment) is Absorbed…
EUCTR2018-000439-29-GB · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2018-000439-29-GB |
|---|---|
| Public title | A Multi-center Study to Evaluate How CCP-020 (Diacerein 1% ointment) is Absorbed in the Blood and Removed from the Body in Patients with Epidermolysis Bullosa (EB) |
| Scientific title | A Multi-center Study to Evaluate the Pharmacokinetics of Diacerein and Rhein and the Safety of Diacerein after Maximum Use, Topical Administration of CCP-020 (Diacerein 1% ointment) to Patients with Epidermolysis Bullosa (EB) |
| Primary sponsor | Castle Creek Pharmaceuticals, LLC |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): yes Therapeutic exploratory (Phase II): no Therapeutic confirmatory - (Phase III): no Therapeutic use (Phase IV): no |
| Countries | United States;France;Netherlands;Germany;United Kingdom |
| Conditions | Epidermolysis Bullosa (EB) MedDRA version: 20.0 Level: PT Classification code 10014989 Term: Epidermolysis bullosa System Organ Class: 10010331 - Congenital, familial and genetic disorders ;Therapeutic area: Diseases [C] - Skin and… |
| Interventions | Product Name: Diacerein Product Code: CCP-020 Pharmaceutical Form: Ointment INN or Proposed INN: DIACEREIN CAS Number: 13739-02-1 Current Sponsor code: CCP-020 Concentration unit: % (W/W) percent weight/weight Concentration type: equal… |
| Registration date | Mar 22, 2018 |
| Target size | 4 |
| Secondary IDs | CCP-020-101;131,384 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: